Trial intelligence / Profile preview

Remune Vaccine with Structured Treatment Interruptions in HIV

NCT00021762Phase 2Withdrawn

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Whole Inactivated Vaccines
01

Overview

Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Remune with Placebo (2 arms). Status: withdrawn.

02

Drugs

Remune
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00021762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00021762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call